Skip to content
Certified ManufacturersFor manufacturers

Vesta Pharmaceuticals, Inc. DBA Vesta Nutra

Indianapolis, IN, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Vesta Pharmaceuticals, Inc. DBA Vesta Nutra is a dietary supplement manufacturer in Indianapolis, IN, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.

Facilities listed
2
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • 5767 Thunderbird Road, Indianapolis, IN 46236, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 5740 Thunderbird Road, Indianapolis, IN 46236, United States

    • Warehousing

How Vesta Pharmaceuticals, Inc. DBA Vesta Nutra compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Vesta Pharmaceuticals, Inc. DBA Vesta Nutra in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 5 food or dietary supplement inspections at facilities matching Vesta Pharmaceuticals, Inc. DBA Vesta Nutra, from 2011 to 2025, as of . 1 found no objectionable conditions and 4 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Indianapolis, Indiana

    Listed by FDA as Vesta Pharmaceuticals, Inc.

    4 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Product received - contamination, deterioration (21 CFR 111.165(e))
    • Master manufacturing record - prepared (21 CFR 111.205(a))
    Full citation text
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength, composition and limits on contamination.

    • Product received - contamination, deterioration (21 CFR 111.165(e))

      You did not hold received product under conditions that will protect against contamination, protect against deterioration and avoid mix-ups.

    • Master manufacturing record - prepared (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    FEI 1819875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Indianapolis, Indiana

    Listed by FDA as Vesta Pharmaceuticals, Inc.

    3 citations posted:

    • Quality control operations - calibration records (21 CFR 111.117(b))
    • Batch record - quality control review; production (21 CFR 111.260(l)(1))
    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
    Full citation text
    • Quality control operations - calibration records (21 CFR 111.117(b))

      Your quality control operations did not include periodically reviewing all records for calibration of instruments and controls.

    • Batch record - quality control review; production (21 CFR 111.260(l)(1))

      Your batch production records did not include documentation that quality control personnel reviewed the batch production record.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components and dietary supplements under conditions that lead to mix-up, contamination, or deterioration.

    FEI 1819875

  • No action indicated · No objectionable conditions found

    Inspected

    Indianapolis, Indiana

    Listed by FDA as Vesta Pharmaceuticals, Inc.

    FEI 1819875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Indianapolis, Indiana

    Listed by FDA as Vesta Pharmaceuticals, Inc.

    7 citations posted:

    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    See all 7 citations
    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not convenient.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Written procedures - components (21 CFR 111.153)

      You did not follow written procedures for the requirements for components of dietary supplements.

    • Written procedures - rejected components, packaging, labels (21 CFR 111.153)

      You did not follow written procedures for the requirements for rejected components, packaging, or labels.

    FEI 1819875

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Indianapolis, Indiana

    Listed by FDA as Vesta Pharmaceuticals, Inc.

    FEI 1819875

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 2 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026